iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Go back to iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)| IBIO, Inc. (NASDAQ: IBIO) | Delayed: 1.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.59 | 52 Week High | $0.80 | |||
| Open | $1.59 | 52 Week Low | $0.34 | |||
| Day High | $1.59 | P/E | N/A | |||
| Day Low | $1.59 | EPS | $-0.08 | |||
| Volume | 164 | |||||
